The VENTOR Clinical Study
CoLabs Medical · NCT06759389
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–75 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 25
- US sites recruiting
- 1
- Study start
- April 4, 2025
- Record last updated
- October 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To evaluate the initial safety and effectiveness of the Ventor Airway System in providing short-term ventilation support in non-breathing subjects during cardiopulmonary resuscitation (CPR) and respiratory arrests.
Being studied: Resuscitation (Ventor)
Conditions: Cardiac Arrest (CA)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults aged 18-75 years, inclusive
- IHCA (non-traumatic)
- At least 4 feet in height
Exclusion Criteria
- Intubated with an endotracheal tube (ET)
- Valid do-not-attempt-resuscitation (DNAR) or study opt-out bracelet (including previous enrollment bracelet)
- LAR or Family member objects to enrollment
- Obvious signs of irreversible death (rigor mortis, dependent lividity, decapitation, transection, decomposition)
- Responsive with an intact gag reflex
- Blunt, penetrating, or burn-related injury, drowning, or electrocution
- Known upper airway foreign body or mass
- Lower airway obstruction
- Dental gap of \< 2 cm
- Ingested caustic substances
- Medicine Admitting Note's medical history is incomplete or has only been completed by an emergency physician.
- Known esophageal disease or facial/perforating neck trauma defined as study candidates with the following medical history:
- Diseases: (Esophageal Varices, Esophageal Cancer, Esophageal Strictures)
- Any patient on the following medications will be excluded: (Oxaliplatin, Leucovorin, Fluorouracil)
- Any patient with the following examination findings will be excluded: (Caput medusae, History or evidence of vomiting blood)
- Known vulnerable subject other Inclusion #3, such as known (e.g.: prisoner, pregnancy, terminal illness, dementia)
- History of medical, surgical or other conditions that, in the opinion of the investigator, would limit study participation
Recruiting US locations
Stony Brook University Hospital
Stony Brook, NY 11794
Site contact: Jacqueline Skarre · 631-444-9033 · Jacqueline.Skarre@stonybrookmedicine.edu
Study contacts (from the official record)
- Clay Nolan · (800) 592-6241 · clayn@colabsmedical.com